An Evaluation of the Validity of the Animal Models of Kawasaki Disease Vasculopathy

Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced withCandida albicanswater-soluble fraction: an animal model of Kawasaki disease

(2014) Kei Takahashi et al.   Modern Rheumatology

Histopathological and Ultrastructural Examinations of Rabbit Coronary Artery Vasculitis Caused by Bovine Serum Albumin: An Animal Model of Kawasaki Disease

(2013) Jijuan Dou et al.   ULTRASTRUCTURAL PATHOLOGY

Marked Acceleration of Atherosclerosis After Lactobacillus casei –Induced Coronary Arteritis in a Mouse Model of Kawasaki Disease

(2012) Shuang Chen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Interleukin-1β Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease

(2012) Youngho Lee et al.   CIRCULATION

Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study

(2012) Jan Marc Orenstein et al.   PLoS One

Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease

(2011) Kei Takahashi et al.   Pediatric Rheumatology

Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease

(2009) A. C. Lau et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Involvement of Innate and Adaptive Immunity in a Murine Model of Coronary Arteritis Mimicking Kawasaki Disease

(2009) D. J. Schulte et al.   JOURNAL OF IMMUNOLOGY

Long-Term Prognosis of Patients with Kawasaki Disease: At Risk for Future Atherosclerosis?

(2009) Ryuji Fukazawa et al.   JOURNAL OF NIPPON MEDICAL SCHOOL

Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight

(2008) Anne H. Rowley et al.   NATURE REVIEWS MICROBIOLOGY